Red blood cell distribution width is worthwhile when interpreted with other inflammatory markers

In a recent issue of Journal of Geriatric Cardiology, we read the article by LIU, et al. with interest. They aimed to investigate whether red cell distribution width (RDW) had a relationship with mortality in elderly patients after percutaneous coronary intervention (PCI). The authors concluded that, RDW is an independent predictor of the increased intermediate-term all-cause mortality in elderly patients after PCI. The easy availability of testing for RDW at no additional cost may encourage its broader use in clinical practice. We would like to thank the authors for their comprehensive contribution. Red blood cell distribution width is a quantitative measure of red blood cell anisocytosis and can be easily determined by routine complete blood counts. Previous studies showed that increased RDW values are associated with poor prognosis in various diseases including coronary artery diseases. Red blood cell distribution width has an important caveat that many conditions can affect it. We can enlist these conditions as ethnicity, neurohumoral activation, renal dysfunction, thyroid disease, hepatic dysfunction, nutritional deficiencies (i.e., iron, vitamin B12 and folic acid), bone marrow dysfunction, inflammatory diseases and chronic or acute systemic inflammation. It deserves special attention, because inflammatory status is directly associated with increased RDW values. RDW itself alone especially without other inflammatory markers may not give healthy information to clinicians. Adding other parameters such as mean platelet volume, neutrophile/lymphocyte ratio, C-reactive protein, procalcitonin, etc., would make this study more precise. Secondly, as the authors conducted the study retrospectively, the time elapsed between sampling and measuring the RDW levels were unknown. As shown in previous studies, delaying blood sample may cause to abnormal results in RDW values. RDW has become popular in recent studies because of its easy assessment. LIU, et al. showed that we can use that easy laboratory test as a prognostic marker in elderly patients after percutaneous coronary intervention. But clinicians must keep in mind that RDW values can affected by many disease states and blood sampling errors.